Gusto Global Overview
- Founded
- 2015
- Status
- Private
- Employees
- 4
- Latest Deal Type
- Angel
- Latest Deal Amount
- $400K
- Investors
- 1
Gusto Global General Information
Description
Developer of a super-computing bioinformatics and predictive modelling platform designed to offer a safer and more effective patient-centric care through disease prevention, early diagnosis, intervention and monitoring. The company's GUST+ bioinformatics and predictive modelling platform integrates advanced computational and microbiological tools to discover and develop novel live bio-therapeutic products (LBPs), enabling doctors and researchers to restore missing functionalities and achieve targeted immune modulation and optimization of metabolic pathways.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
- 400 Park Offices Drive
- Suite 104
- Morrisville, NC 27560
- United States
Gusto Global Timeline
Gusto Global Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 19-Jun-2019 | $400K | 00.00 | Completed | Startup | |
| 2. Angel (individual) | 09-Dec-2017 | 000 | 000 | Completed | Startup | |
| 1. Seed Round | 01-Jan-2017 | Completed | Startup |
Gusto Global Executive Team (5)
Gusto Global Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGusto Global Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Fennebresque & Co. | Investment Bank | Minority | 000 0000 | 000000 0 |